Scientific Founders Senior Management Scientific Advisory Board Board Members SCIENTIFIC ADVISORY BOARD In addition to our Founders the AdipoGenix Scientific Advisory Board includes: George A. Bray, M.D. Dr. Bray is an internationally recognized obesity researcher and clinical authority in the treat...

Our mission is to develop pharmaceuticals that treat obesity. We support that mission with a distinctive approach, targeting fat cells with drugs that reduce fat, and with a novel drug discovery technology, the capability to isolate fat precursor cells from human fat tissue, stimulate these precurso...

Overview Obesity Facts Why Target the Fat Cell? Overview AdipoGenix, Inc. is a Boston-based biopharmaceutical company developing small molecule pharmaceuticals to treat obesity and its co-morbidities. Obesity is too much fat, and the pharmacologic target for our drug discovery programs is human fat ...

Press Releases Clippings Directions FROM THE NORTH: Follow Route 1 (Via Mystic/Tobin Bridge) to Rt 93 South Take Exit 18 (Mass Ave) At traffic light, take right onto access road; stay in right lane At end of access road, turn right onto Massachusetts Ave See to AdipoGenix below FROM LOGAN AIRPORT: G...

Press Releases Clippings Press Release Adipogenix Appoints Nils Bergenhem, Ph.D. as Chief Scientific Officer BOSTON, June 17, 2005 AdipoGenix Inc., a biopharmaceutical company developing small molecule therapies for obesity, type 2 diabetes and associated co-morbidities, today announced the appointm...